bf/NASDAQ:UBX_icon.jpeg

COM:UNITYBIOTECHNOLOGY

Unity Biotechnology

  • Stock

USD

Last Close

1.16

22/11 21:00

Market Cap

24.34M

Beta: -

Volume Today

56.99K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
1.67M
-
3.61M
116.19%
5.02M
38.85%
3.87M
22.82%
2.27M
41.33%
1.89M
16.91%
1.58M
16.03%
average receivables
691K
-
691K
0%
book value per share
-120.84
-
264.28
318.71%
56.84
78.49%
27.67
51.32%
16.29
41.11%
10.67
34.50%
7.04
34.03%
0.00
99.97%
capex per share
-6.53
-
-4.91
24.73%
-0.45
90.90%
-0.36
18.69%
-0.13
65.07%
-0.03
72.49%
-0.01
71.06%
capex to depreciation
-14.67
-
-1.30
91.17%
-0.58
55.24%
-0.60
2.72%
-0.19
68.55%
-0.07
63.85%
-0.04
34.96%
capex to operating cash flow
0.14
-
0.04
67.82%
0.02
49.30%
0.02
1.90%
0.01
62.34%
0.00
47.52%
0.00
56.53%
capex to revenue
-1.22
-
-0.04
-
-0.41
897.97%
cash per share
259.75
-
251.68
3.11%
60.54
75.95%
29.22
51.73%
19.21
34.27%
15.78
17.85%
9.98
36.73%
0.00
99.97%
days of inventory on hand
days payables outstanding
days sales outstanding
365
-
debt to assets
0.41
-
0.41
1.78%
0.38
7.88%
0.36
5.91%
debt to equity
0.77
-
0.87
12.97%
0.71
18.15%
0.83
17.00%
dividend yield
0.13
-
0.00
99.94%
earnings yield
-0.53
-
-0.78
46.88%
-0.17
78.70%
-0.24
43.23%
-0.34
44.80%
-0.74
113.75%
-2.22
201.29%
-0.00
99.94%
enterprise value
-32.05M
-
49.93M
255.78%
444.39M
789.97%
277.06M
37.65%
307.70M
11.06%
100.14M
67.45%
60.64M
39.45%
28.52B
46,928.95%
enterprise value over ebitda
3.44
-
-1.13
132.75%
-6.31
460.22%
-3.00
52.49%
-3.42
14.02%
-1.74
49.13%
-1.08
38.18%
-638.43
59,249.74%
ev to operating cash flow
1.95
-
-1.30
166.60%
-7.85
502.89%
-3.83
51.25%
-3.93
2.68%
-2.22
43.42%
-1.19
46.53%
ev to sales
36.13
-
20.93
-
256.94
1,127.41%
free cash flow per share
-54.23
-
-116.51
114.82%
-20.48
82.42%
-16.96
17.15%
-15.53
8.47%
-8.11
47.78%
-5.38
33.59%
free cash flow yield
-0.33
-
-0.70
114.82%
-0.13
82.00%
-0.24
86.84%
-0.30
25.94%
-0.56
87.41%
-1.97
253.88%
graham net net
-142.26
-
222.16
256.17%
53.22
76.04%
22.23
58.23%
4.77
78.54%
4.11
13.86%
3.93
4.40%
0.00
99.99%
graham number
490.40
-
878.93
79.23%
185.91
78.85%
103.37
44.40%
81.37
21.28%
50.82
37.54%
31.04
38.92%
0.01
99.97%
income quality
0.54
-
0.86
59.26%
0.74
13.72%
0.88
18.91%
0.83
5.28%
0.74
11.10%
0.85
14.75%
intangibles to total assets
0
-
0
0
0
0
0
0
0
interest coverage
-23.99
-
-72.70
-
-17.84
75.47%
-16.18
9.28%
18.22
212.58%
interest debt per share
1.17
-
12.74
-
9.81
23.01%
5.36
45.31%
0.00
99.97%
inventory turnover
invested capital
0.77
-
0.87
12.97%
0.71
18.15%
0.83
17.00%
market cap
57.23M
-
57.23M
0%
459.67M
703.17%
314.53M
31.57%
266.53M
15.26%
81.49M
69.43%
26.01M
68.08%
28.51B
109,503.63%
net current asset value
-44.77M
-
77.70M
273.53%
152.28M
95.99%
98.97M
35.01%
27.43M
72.29%
25.36M
7.53%
39.03M
53.91%
9.31M
76.14%
net debt to ebitda
9.59
-
0.16
98.28%
0.22
31.75%
0.41
86.95%
-0.46
212.79%
-0.32
29.18%
-0.61
89.49%
-0.08
86.38%
net income per share
-88.45
-
-129.91
46.88%
-27.02
79.20%
-17.16
36.49%
-18.06
5.23%
-10.76
40.44%
-6.08
43.46%
-0.00
99.96%
operating cash flow per share
-47.71
-
-111.59
133.92%
-20.03
82.05%
-16.60
17.12%
-15.40
7.23%
-8.07
47.58%
-5.37
33.42%
payables turnover
receivables turnover
1
-
research and ddevelopement to revenue
27.04
-
8.03
-
156.18
1,846.12%
return on tangible assets
-0.31
-
-0.44
39.14%
-0.42
3.77%
-0.50
17.55%
-0.59
18.70%
-0.48
18.08%
-0.46
3.54%
-0.61
30.66%
revenue per share
4.02
-
0.86
-
0.02
97.10%
roe
0.73
-
-0.49
167.16%
-0.48
3.28%
-0.62
30.47%
-1.11
78.70%
-1.01
9.07%
-0.86
14.29%
-1.40
62.48%
roic
0.63
-
-0.49
178.28%
-0.51
4.93%
-0.68
31.56%
-0.51
24.86%
-0.40
21.98%
-0.39
0.96%
-0.59
50.62%
sales general and administrative to revenue
6.96
-
4.82
-
88.77
1,741.87%
shareholders equity per share
-120.84
-
264.28
318.71%
56.84
78.49%
27.67
51.32%
16.29
41.11%
10.67
34.50%
7.04
34.03%
0.00
99.97%
stock based compensation to revenue
2.20
-
2.41
-
39.74
1,545.66%
tangible asset value
-41.54M
-
90.84M
318.71%
160.69M
76.89%
120.71M
24.88%
82.88M
31.34%
59.57M
28.13%
66.85M
12.22%
28.40M
57.52%
tangible book value per share
-120.84
-
264.28
318.71%
56.84
78.49%
27.67
51.32%
16.29
41.11%
10.67
34.50%
7.04
34.03%
0.00
99.97%
working capital
89.72M
-
80.98M
9.74%
156.38M
93.11%
112.27M
28.21%
86.40M
23.04%
73.89M
14.49%
76.92M
4.10%
38.77M
49.60%

All numbers in USD (except ratios and percentages)